Leveraging university research to advance global health

JAMA

Volumn 298, Issue 16, 2007, Pages 1934-1936

  Chokshi, Dave A ^a   Rajkumar, Rahul ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; EMTRICITABINE; ENFUVIRTIDE; LAMIVUDINE; MONOCLONAL ANTIBODY; STAVUDINE; WART VIRUS VACCINE;

HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; NOTE; PATIENT RIGHT; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UNIVERSITY; ARTICLE; DRUG INDUSTRY; FINANCIAL MANAGEMENT; HEALTH; HEALTH ECONOMICS; PUBLIC HEALTH; TECHNOLOGY;

BIOMEDICAL RESEARCH; DRUG INDUSTRY; ECONOMICS, MEDICAL; FINANCIAL SUPPORT; PUBLIC HEALTH; TECHNOLOGY TRANSFER; UNIVERSITIES; WORLD HEALTH;

EID: 35448949523     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.298.16.1934     Document Type: Note

References (25)

1. Chirac P, Torreele E. Global framework on essential health R&D. Lancet. 2006;367(9522):1560-1561.
2. Medecins Sans Frontieres. Untangling the Web of Price Reductions: A Pricing Guide for Developing Countries. 10th ed. Geneva, Switzerland: Medecins Sans Frontieres Campaign for Access to Essential Medicines; 2007.
3. Kim JY, Farmer P. AIDS in 2006-moving toward one world, one hope? N Engl J Med. 2006;355(7):645-647.
4. Wainberg MA. Generic HIV drugs-enlightened policy for global health. N Engl J Med. 2005;352(8):747-750.
5. Westerhaus M, Castro A. How do intellectual property law and international trade agreements affect access to antiretroviral therapy? PLoS Med. 2006;3(8):e332.
6. Moses H III, Dorsey ER, Matheson DH, Thier SO. Financial anatomy of biomedical research. JAMA. 2005;294(11):1333-1342.
7. Association of University Technology Managers. AUTM Licensing Survey: FY 2005. Northbrook, IL: Association of University Technology Managers; 2007.
8. US Food and Drug Administration Web site. Drugs used in the treatment of HIV infection. http://www.fda.gov/oashi/aids/virals.html. Accessed September 16, 2007.
9. Kapczynski A, Crone ET, Merson M. Global health and university patents. Science. 2003;301(5640):1629.
10. Chen I. Thinking big about global health. Cell. 2006;124(4):661-663.
11. Salicrup LA, Fedorkova L. Challenges and opportunities for enhancing biotechnology and technology transfer in developing countries. Biotechnol Adv. 2006;24(1):69-79.
12. World Health Organization. Preventing Chronic Diseases: A Vital Investment. Geneva, Switzerland: World Health Organization; 2005.
13. Stanford University Web site. In the public interest: nine points to consider in licensing university technology, March 6. http://news-service. stanford.edu/news/2007/march7/gifs/whitepaper.pdf. Accessed September 16, 2007.
14. Commission on Innovation; Intellectual Property Rights, and Public Health of the World Health Organization. Public Health, Innovation and Intellectual Property Rights. Geneva, Switzerland: World Health Organization; 2006.
15. Brewster A, Chapman A. Facilitating humanitarian access to pharmaceutical and agricultural innovation. Innovation Strategy Today. 2005;1(3):14.
16. Kapczynski A, Chaifetz S, Katz Z, Benkler Y. Addressing global health inequities: an open licensing approach for university innovations. Berkeley Technol Law J. 2005;20(2):1031-1114.
17. Chaifetz S, Chokshi DA, Rajkumar R, Scales D, Benkler Y. Closing the access gap for health innovations. Global Health. 2007;3:1.
18. Haynes B. Global health and reducing disparities: the role of the university. Presented at: Institute of Medicine Regional Meeting; Durham, NC; May 4, 2005.
19. Hotez P. The George Washington University Neglected Tropical Diseases Initiative. Washington, DC: George Washington University Center for Neglected Diseases; 2005.
20. Coloma J, Harris E. Open-access science. PLoS Pathog. 2005;1(2):e21.
21. Moran M, Ropars A, Guzman J, Diaz J, Garrison C. The New Landscape of Neglected Disease Drug Development. London, England: Wellcome Trust; 2005.
22. Chong CR, Sullivan DJ Jr. New uses for old drugs. Nature. 2007;448(7154):645-646.
23. Technology Managers for Global Health. Academic Licensing to Global Health Product Development Partnerships. Iowa City, IA: Technology Managers for Global Health; 2006.
24. Freire MC. Technology transfer's next frontier: global health as a new bottom line. J Assoc University Technol Managers. 2002;14:1-5.
25. Sobolski GK, Barton JH, Emanuel EJ. Technology licensing. JAMA. 2005;294(24):3137-3140.